CNR1

Chr 6

cannabinoid receptor 1

Also known as: CANN6, CB-R, CB1, CB1A, CB1K5, CB1R, CNR

The protein is a G-protein coupled receptor for endogenous cannabinoids that regulates neurotransmission, energy metabolism, and inflammatory responses throughout the central nervous system and peripheral tissues. Mutations cause early-onset epileptic encephalopathy and neurodevelopmental disorders with seizures, developmental delay, and movement abnormalities. The gene shows autosomal recessive inheritance and demonstrates significant constraint against loss-of-function variants.

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 0.60
Clinical SummaryCNR1
Population Constraint (gnomAD)
Moderately constrained gene (pLI 0.51) — some intolerance to loss-of-function variants.
📋
ClinVar Variants
14 unique Pathogenic / Likely Pathogenic· 40 VUS of 70 total submissions
💊
Clinical Trials
6 active or recruiting trials — potential therapeutic options may be available

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.60LOEUF
pLI 0.507
Z-score 2.42
OE 0.19 (0.080.60)
Moderately constrained

Typical tolerance to LoF variation

Missense Constraint
2.62Z-score
OE missense 0.57 (0.500.65)
165 obs / 290.7 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios
LoF OE0.19 (0.080.60)
00.351.4
Missense OE0.57 (0.500.65)
00.61.4
Synonymous OE1.05
01.21.6
LoF obs/exp: 2 / 10.5Missense obs/exp: 165 / 290.7Syn Z: -0.43
DN
0.6743th %ile
GOF
0.80top 10%
LOF
0.4234th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

70 submitted variants in ClinVar

Classification Summary

Pathogenic14
VUS40
Likely Benign9
Benign1
14
Pathogenic
40
VUS
9
Likely Benign
1
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
14
0
14
Likely Pathogenic
0
0
0
0
0
VUS
0
36
4
0
40
Likely Benign
0
0
0
9
9
Benign
0
0
0
1
1
Total036181064

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

CNR1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold
Clinical Literature
Open Research Assistant →